My laboratory examines the use of various diet-derived as potential chemotherapeutic agents for hormone-refractory or advanced prostate cancer. Currently, there is no curative therapy available once prostate cancer has metastasized or progressed to advanced disease. It is therefore imperative to develop alternative effective therapies, such as chemotherapeutic agents with novel mechanisms of action.
Students have the opportunity to participate in a laboratory experience that extends from computational modeling and data analytics to cellular and molecular investigations in experimental cancer therapeutics while interrogating androgen receptor function (signaling), epigenetics and prostate cancer progression.
